Skip to main content

Press Releases

No Data

Gov. Blagojevich awards $1.5 million in Ticket for the Cure grants for breast cancer research

Press Release - Friday, February 08, 2008

CHICAGO -Governor Rod R. Blagojevich today awarded Ticket for the Cure grants totaling $1.5 million to researchers at five Illinois universities.  Illinois Department of Public Health Director Dr. Damon T. Arnold made the announcement at the University of Chicago, which is receiving a total of $425,000 to four researchers to find new methods to detect, prevent, screen and treat breast cancer.  
 
Launched in January 2006, Ticket for the Cure is the nation's first lottery ticket dedicated to helping fund breast cancer research, early detection, education and patient services throughout the state. One hundred percent of the net proceeds from Ticket for the Cure support programs and research initiatives. 
 
"Since we expanded the Illinois Breast and Cervical Cancer Program last October to all women, more than 7,000 women have signed up to take advantage of potentially life-saving screenings and treatment.  These grants build on our efforts to make sure women to receive the best preventative, detection and treatment options that new research can offer," said Gov. Blagojevich.
 
 Last year, 52 Illinois organizations were awarded a total of $2.8 million in Ticket for the Cure community program grants to further breast cancer education efforts and to help provide supportive services for breast cancer victims and their families. 
 
"So many lives are touched by breast cancer.  Almost all of us know of someone affected by breast cancer.  These Ticket for the Cure grants will help researchers find new ways to help reduce the number of women who are diagnosed with breast cancer or find better treatments so that women don't have to suffer and their chance of survival increase," said Dr. Arnold.
 
"The invaluable aspect of this funding from Ticket from the Cure proceeds is that it will allow us to pursue a more innovative approach to predicting, and hopefully preventing, breast cancer metastasis than would be possible with federal funds due to the limitations on funding criteria and the current research funding crisis," said Kay MacLeod, Ph.D., an assistant professor in the Ben May Department for Cancer Research at the University of Chicago Medical Center.
 
Net revenue from the sale of Ticket for the Cure is deposited into an interest bearing account in the State Treasury called the Ticket for the Cure Fund.  The Illinois General Assembly appropriates this money solely to the Illinois Department of Public Health (IDPH), which awards grants to public and private entities in Illinois.  The Ticket for the Cure Board, a special advisory board, reviews and approves all grants funded by Ticket for the Cure revenue.
 
"As a husband of a two time breast cancer survivor, I know the critical need for research funding.  Every dollar toward breast cancer research brings us closer to improved treatment as well as finding the cause and cure," said Leonard Thomas, Chair of the "Ticket for the Cure" Board.
 
For more information on the Ticket for the Cure please visit www.illinoislottery.com.
Women can find out how to get breast and cervical cancer screenings and treatment through Governor Blagojevich's Illinois Breast and Cervical Cancer Program by logging on to www.cancerscreening.illinois.gov.  For more information on women's health and programs visit www.idph.state.il.us or call the Women's Health Line at 888-522-1282.  For TTY (hearing impaired use only) call 800-547-0466.
 
 
Illinois Department of Public Health

Office of Women's Health
Ticket for the Cure - Research Grants
 
University
Researcher
Purpose
Amount
Loyola University
Kimberly E. Foreman, PhD
Targeting Notch Signaling and Hepatocyte Growth Factor in Breast Cancer
$100,000
Loyola University
Paola Rizzo, PhD
Targeting Breast Cancer Through the Cross-Talk Between Estrogen and Notch
$125,000
Loyola University
Christopher M. Wiethoff, Pharm D, MS, PhD
Genome-wide RNAi for the Identification of Breast Cancer Determinants of Adenovirus Gene Therapy
$125,000
Northwestern University
Jacqueline Jeruss, MD, PhD
Three Dimensional Cellular Array for the Molecular Assessment of Breast Cancer
$100,000
Northwestern University
Anait Levenson, MD, PhD
Molecular Determinants of Hormone-Dependent Breast Cancer Bone Metastases
$100,000
Southern Illinois University
Yin-Yuan Mo, PhD
MicroRNA-21-Mediated Gene Regulation in Breast Cancer
$125,000
Southern Illinois University
Daotai Nie, PhD, MS, BS
TP as a Target to Block EMT During Invasion and Metastasis of Breast Cancer.
$100,000
University of Chicago
Richard Baker Jones, BS, PhD
Characterization of Novel ErbB Therapeutic Targets in Breast Cancer
$100,000
University of Chicago
Kay F. MacLeod, PhD
Identification of BNOP3 as a Breast Cancer Metastasis Suppresor
$125,000
University of Chicago
Peirs David Nash, BSc, PhD
Control of the Metastatic and Migration Protein CXCR4 by a Ubiquitin Isopeptidase
$100,000
University of Chicago
Xiaochuan Pan, PhD
Development of Innovative MRI Methods to Improve Early Detection of Breast Cancer
$100,000
University of Illinois
Therese A. Dolecek, PhD
Pilot Study Evaluation of Breast Cancer Disparities Using Large Data Set Linkage
$100,000
University of Illinois
Andrei L. Gartel
New use for Thiopeptide Antibiotics as Drugs Against Breast Cancer
$100,000
University of Illinois
Garth Rauscher, PhD
Ethnic Disparity in Symptomatic Breast Cancer Awareness Following Routine Mammography
$100,000
 
 
 
$1,500,000

Press Releases

No Data